FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:931-932 February 26, 2009 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Mallet, L. PubMed Citation

To the Editor: The study of subthalamic nucleus stimulation for the treatment of severe obsessive–compulsive disorder (OCD), reported by Mallet and colleagues (Nov. 13 issue),¹ appears to be problematic for several reasons. First, on the basis of the clinical information given, such as age at onset, duration of disease, and prior treatment, we think the patients may not have been selected carefully enough. A major proportion of the study patients met the criteria for treatment-resistant OCD if anything,² and thus might not have had an indication for neurosurgical treatment.

Second, OCD is an etiologically heterogeneous disorder that mainly involves the . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2010 Massachusetts Medical Society. All rights reserved.